Clinical Pathways Search Results

The clinical pathway for child with fever guides early identification, evaluation and management of patients with high-risk factors or severe signs/symptoms of disease.

The Prevention of Acute Chemotherapy-Induced Nausea and Vomiting Clinical Pathway provides guidance for selecting anti-emetics and non-pharmacologic therapies for patients receiving chemotherapy.

Treatment of patients with active COVID-19 disease with guidance on severity of illness, recommendations for antivirals, steroids, immunomodulators, and convalescent plasma administration.

The PICU neonatal hyperammonemia pathway guides the care for infants < 30 days of age referred or presenting to CHOP for acute care for any abnormal or elevated ammonia level.

The Beckwith-Wiedemann Syndrome (BWS) Clinical Pathway provides guidance of care for neonates/infants born at the CHOP SDU or referred from outside institutions for further evaluation and treatment with overgrowth features such as macroglossia, hyperinsulinism, omphalocele and/or a constellation of findings suspicious for BWS.

The neonatal abstinence syndrome (NAS)/neonatal opioid withdrawal syndrome (NOWS) clinical pathway provides a care plan to optimize non-pharmacologic management for infants and maximize maternal-infant bonding

This pathway provides a detailed overview of preoperative, intraoperative, and postoperative care for the infant diagnosed with CDH during their initial hospitalization.  

The constipation clinical pathway outlines the care plan for diagnosis and treatment of functional constipation in the emergency department and inpatient settings.

The CICU pathway for ventilator weaning provides guidance on the management and weaning of conventional mechanical ventilation and extubation readiness in children in the Cardiac Intensive Care Unit.

The ventricular shunt obstruction/infection pathway details the specific care necessary in the evaluation and treatment of a child with a suspected ventricular shunt obstruction or infection.